Αρχική World News Researchers Have Harnessed a Compound from a Common Plant Called Feverfew to...

Researchers Have Harnessed a Compound from a Common Plant Called Feverfew to Fight Cancer

There may soon be one more effective treatment option for people with cancer, as researchers have just discovered a way to manipulate a compound found in a common garden plant to fight cancer.The study, conducted at the University of Birmingham, involved extracting a compound called parthenolide from a common flowering plant called feverfew (part of the daisy family) and modifying it to be able to kill chronic lymphocytic leukaemia (CLL) cells in the laboratory.Feverfew is already known to have a wide variety of medicinal properties. It is sold in many health food stores for the purpose of combatting migraines and other aches and pains. But using it to fight cancer is a new breakthrough.Photo: Adobe Stock/Peter Kovacs
The parthenolide compound extracted from the feverfew works by increasing the number of reactive oxygen species (ROS) in the cells. Cancer cells already have a high concentration of these unstable molecules, so the addition of more of them causes the cell to reach a point where it can no longer sustain its own life.“There are several effective treatments for CLL, but after a time the disease in some patients becomes resistant,” explains lead researcher Dr. Angelo Agathanggelou, of the Institute of Cancer and Genomic Studies. “We were interested in finding out more about the potential of parthenolide. With expertise from colleagues in the School of Chemistry we’ve been able to demonstrate that this compound shows real promise and could provide alternative treatment options for CLL patients.”The researchers hope their discovery will give new hope to cancer patients whose diseases have become resistant to other treatments. Once the compound is made into a drug and approved for the use of cancer treatment, it may also be useful in the treatment of other types of cancers besides CLL. For now, however, it’s a big jump just to have shown that it’s possible to create a cancer-fighting compound from feverfew plants.
Photo: Adobe Stock/kwanchaift“This research is important not only because we have shown a way of producing parthenolide that could make it much more accessible to researchers, but also because we’ve been able to improve its ‘drug-like’ properties to kill cancer cells,” says Professor John Fossey, of the University’s School of Chemistry. “It’s a clear demonstration that parthenolide has the potential to progress from the flowerbed into the clinic.”We’re looking forward to seeing what researchers are able to do with this amazing plant going forward, as well as all the other ways cancer will be fought in the future. Thank you, all those who work in this branch of science, for your contributions to healthy lives!
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Making the most of your ‘eureka’ moment: getting from the science to the clinic

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an...

Black Women Have Nearly Three Times the Risk of Developing Triple Negative Breast Cancer, Study Says

Triple-negative breast cancer is notoriously hard to treat and tends to be more aggressive. It’s also more common among Black women. A new study...

Pioneer in Autism Diagnosis And Treatment Dies At 97

The community is mourning the loss of a true pioneer in autism diagnosis and treatment who strongly advocated for education for people with autism. Dr....

A Novel Combination of Cabozantinib Plus Atezolizumab Demonstrates Encouraging Activity and Acceptable Tolerability in Advanced RCC

In the COSMIC-021 study, cabozantinib plus atezolizumab demonstrated encouraging clinical activity in patients with advanced renal cell carcinoma (RCC). Robust clinical activity was observed...

A celebration of peer review

Peer review is an incredibly important part of how we maintain the excellence of the research we fund. As part of Peer Review Week,...

People with Intellectual Disability at Increased Risk of Cancer

People with intellectual disability are at an increased risk of any cancer, as well as several specific cancer types. The findings from a population-based...